P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY

P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY

Detalhes bibliográficos
Principais autores:	Rafat Abonour, Robert Rifkin, Sikander Ailawadhi, Hans C. Lee, Christina Gasparetto, Lynne Wagner, Brian Durie, James Hardin, Howard Terebelo, Mohit Narang, Kathleen Toomey, Yuexin Tang, Sujith Dhanasiri, Jasmeet Anand, Edward Yu, Thomas Marshall, Liang Liu, Sundar Jagannath
Formato:	Artigo
Idioma:	English
Publicado em:	Wiley 2023-08-01
coleção:	HemaSphere
Acesso em linha:	http://journals.lww.com/10.1097/01.HS9.0000970564.52503.e2

Registros relacionados

Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
por: Sikander Ailawadhi, et al.
Publicado em: (2024-11-01)

Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect® MM Registry
por: Hans C. Lee, et al.
Publicado em: (2021-07-01)

Connect MM Registry as a national reference for United States multiple myeloma patients
por: Sikander Ailawadhi, et al.
Publicado em: (2020-01-01)

Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
por: Sundar Jagannath, et al.
Publicado em: (2018-07-01)

Lenalidomide-Associated ITP
por: Christina I. Herold, et al.
Publicado em: (2011-01-01)

Porche 915 1969-76 autobook/
por: 206830 Ball, Kenneth
Publicado em: (1978)

Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1
por: María-Victoria Mateos, et al.
Publicado em: (2017-10-01)

Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib–lenalidomide–dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study
por: Lee, HC, et al.
Publicado em: (2024)

9.15 Biochemistry and Pharmacology of Synaptic Transmission, Fall 2001
por: Wurtman, Richard J., 1936-
Publicado em: (2001)

Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
por: S. A. Tuchman, et al.
Publicado em: (2012-01-01)

Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma
por: C. Cerchione, et al.
Publicado em: (2020-10-01)

P901: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN LENALIDOMIDE–PRETREATED MULTIPLE MYELOMA: A SUBANALYSIS OF OPTIMISMM BY FRAILTY
por: A. Oriol, et al.
Publicado em: (2022-06-01)

P965: FOLLOW-UP ANALYSIS OF THE RANDOMIZED PHASE II TRIAL OF BORTEZOMIB, LENALIDOMIDE, DEXAMTHASONE WITH/WITHOUT ELOTUZUMAB FOR NEWLY DIAGNOSED, HIGH RISK MULTIPLE MYELOMA (SWOG-1211)
por: S. Usmani, et al.
Publicado em: (2022-06-01)

9.15 / 9.150 Biochemistry and Pharmacology of Synaptic Transmission, Fall 2003
por: Wurtman, Richard J., 1936-
Publicado em: (2003)

915 nm pumping kilowatt fiber oscillator with high optical-to-optical efficiency
por: Xin Chen, et al.
Publicado em: (2024-11-01)

A new 915 MHz coaxial-line-based microwave plasma source
por: Robert Miotk, et al.
Publicado em: (2024-07-01)

Optimal Ate Pairing on Elliptic Curves with Embedding Degree $9,15$ and $27$
por: Emmanuel Fouotsa, et al.
Publicado em: (2020-04-01)

915 MHz microwave-assisted laparoscopic partial splenectomy: A case series
por: Qiyi Zhang, et al.
Publicado em: (2020-01-01)

A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma
por: Ajai Chari, et al.
Publicado em: (2017-08-01)

Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma
por: Seunghee Kim-Schulze, et al.
Publicado em: (2024-04-01)

ARTÍCULO 915 DEL CÓDIGO CIVIL: UNA SOLUCIÓN JURISPRUDENCIAL A LA LIMITACIÓN DE LAS ACCIONES TRADICIONALES Article 915 of the civil code: a jurisprudential solution to the limitation of the traditional actions
por: Arturo Selman Nahum
Publicado em: (2011-01-01)

Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14)
por: Anna Kalff, et al.
Publicado em: (2021-09-01)

Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4
por: Doris K. Hansen, et al.
Publicado em: (2024-08-01)

Coseismic slip and afterslip of the Great Mw 9.15 Sumatra-Andaman earthquake of 2004
por: Chlieh, Mohamed, et al.
Publicado em: (2012)

Measurements and Models of 915 MHz LoRa Radio Propagation in an Underground Gold Mine
por: Philip Branch
Publicado em: (2022-11-01)

Analysis of Asphericity and Corneal Longitudinal Spherical Aberration of 915 Chinese Myopic Adult Eyes
por: Zhang J, et al.
Publicado em: (2023-02-01)

Surface energy arising from the behavior of lipid molecules in the water via Γ-convergence
por: Luca Lussardi, et al.
Publicado em: (2013-01-01)

P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
por: R. M. Rifkin, et al.
Publicado em: (2022-06-01)

Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasone
por: Karthik Ramasamy, et al.
Publicado em: (2024-02-01)

Atmospheric pressure microwave (915 MHz) plasma for hydrogen production from steam reforming of ethanol
por: Robert Miotk, et al.
Publicado em: (2024-06-01)

Optimization of Nd-Doped LMA Fibers for High-Power Laser Emission Near 915 nm
por: Raphael Florentin, et al.
Publicado em: (2024-01-01)

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients
por: Elisa Rumi, et al.
Publicado em: (2011-03-01)

The use of data from 915 MHz profilers in analysis of ozone episodes in San Diego, California
por: Virginia J. Bigler-Engler, et al.
Publicado em: (1998-12-01)

Hydrogen production by the steam reforming of synthetic biogas in atmospheric-pressure microwave (915 MHz) plasma
por: Bartosz Hrycak, et al.
Publicado em: (2023-02-01)

Potential of Sub-GHz Wireless for Future IoT Wearables and Design of Compact 915 MHz Antenna
por: Adolfo Di Serio, et al.
Publicado em: (2017-12-01)

A Small 915MHz Receiving Antenna for Wireless Power Transmission Aimed at Medical Applications
por: Toshihiro Kumagai, et al.
Publicado em: (2014-01-01)

Therapy of Angiosarcoma with Thalidomide and Lenalidomide
por: M. Jules Mattes, et al.
Publicado em: (2021-11-01)

Impact of ixazomib‐lenalidomide‐dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging‐markets subgroup of the TOURMALINE‐MM1 trial
por: Andrew Spencer, et al.
Publicado em: (2022-11-01)

LENALIDOMIDE RETREATMENT IN A PATIENT WITH RELAPSED MULTIPLE MYELOMA WHO HAD PREVIOUSLY RESPONDED TO LENALIDOMIDE
por: Vincenzo Federico
Publicado em: (2014-08-01)

Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma
por: James L. Rubenstein, et al.
Publicado em: (2018-07-01)